Nandrolone hexyloxyphenylpropionate
| |
Clinical data | |
---|---|
Trade names | Anador, Anadur, Anadurine |
Synonyms | 19-Nortestosterone 17β-(3-(4-hexyloxy)phenyl)propionate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
Pharmacokinetic data | |
Elimination half-life | Intramuscular: 21 days[1] |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C33H46O4 |
Molar mass | 506.716 g/mol |
3D model (JSmol) | |
| |
|
Nandrolone hexyloxyphenylpropionate (brand names Anador, Anadur, Anadurine), also known as 19-nortestosterone 17β-(3-(4-hexyloxy)phenyl)propionate, is a synthetic androgen and anabolic steroid and a nandrolone ester that is marketed in France, Denmark, Austria, Luxembourg, and Turkey.[2][3][4][5] It has been studied as a potential long-acting injectable male contraceptive, though it has not been marketed for this indication.[6] Approximately 70% of men became azoospermic, while the remaining men all became oligospermic.[6]
See also
References
- ↑ Geraline C. Lin; Lynda Erinoff (July 1996). Anabolic Steroid Abuse. DIANE Publishing. pp. 125–. ISBN 978-0-7881-2969-8.
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 660–. ISBN 978-1-4757-2085-3.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 716–717. ISBN 978-3-88763-075-1.
- ↑ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
- ↑ Ashraf Mozayani; Lionel Raymon (15 October 2003). Handbook of Drug Interactions: A Clinical and Forensic Guide. Springer Science & Business Media. pp. 501–. ISBN 978-1-59259-654-6.
- 1 2 Anita H. Payne; Matthew P. Hardy (28 October 2007). The Leydig Cell in Health and Disease. Springer Science & Business Media. pp. 423–. ISBN 978-1-59745-453-7.
Progestogens (and progestins) |
| ||||
---|---|---|---|---|---|
Antiprogestogens |
| ||||
|
AR |
| ||||||
---|---|---|---|---|---|---|---|
GPRC6A |
| ||||||
|
PR |
| ||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
| ||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.